ASX - By Stock
|
ACW |
Re:
11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
|
|
snouty
|
80 |
28K |
3 |
02/06/20 |
02/06/20 |
ASX - By Stock
|
80
|
28K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Rubbing my ball
|
|
snouty
|
1.7K |
979K |
13 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
1.7K
|
979K
|
13
|
|
ASX - By Stock
|
IME |
Re:
Ann: Appendix 3Y-Douglas Flynn
|
|
snouty
|
2 |
1.0K |
6 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
2
|
1.0K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER-Vaxx Immunotherapy Patent Granted in US
|
|
snouty
|
69 |
48K |
5 |
14/01/20 |
14/01/20 |
ASX - By Stock
|
69
|
48K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
IXC - My Thesis
|
|
snouty
|
10 |
4.4K |
0 |
20/11/19 |
20/11/19 |
ASX - By Stock
|
10
|
4.4K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Tomorrow
|
|
snouty
|
15 |
6.5K |
11 |
20/11/19 |
20/11/19 |
ASX - By Stock
|
15
|
6.5K
|
11
|
|
ASX - By Stock
|
IMU |
RM Williams Reward
|
|
snouty
|
7 |
6.1K |
8 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
7
|
6.1K
|
8
|
|
ASX - By Stock
|
IMU Biotech |
Re:
IMU Technicals - Breakout of range on significant increase in volume
|
|
snouty
|
91 |
53K |
10 |
08/11/19 |
08/11/19 |
ASX - By Stock
|
91
|
53K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Great national media coverage today...
|
|
snouty
|
124 |
86K |
8 |
08/11/19 |
08/11/19 |
ASX - By Stock
|
124
|
86K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Great national media coverage today...
|
|
snouty
|
124 |
86K |
16 |
08/11/19 |
08/11/19 |
ASX - By Stock
|
124
|
86K
|
16
|
|
ASX - By Stock
|
ACW |
Re:
Ann: R&D Tax Incentive rebate received of $4.58 million
|
|
snouty
|
201 |
57K |
13 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
201
|
57K
|
13
|
|
ASX - By Stock
|
IME |
Re:
IME Upcoming Price Catalysts
|
|
snouty
|
31 |
11K |
0 |
28/07/19 |
28/07/19 |
ASX - By Stock
|
31
|
11K
|
0
|
|
ASX - By Stock
|
SPX |
Re:
Ann: Change in substantial holding
|
|
snouty
|
10 |
7.5K |
4 |
11/07/19 |
11/07/19 |
ASX - By Stock
|
10
|
7.5K
|
4
|
|
ASX - By Stock
|
SPX |
Re:
Ann: Change in substantial holding
|
|
snouty
|
10 |
7.5K |
4 |
10/07/19 |
10/07/19 |
ASX - By Stock
|
10
|
7.5K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Therapeutics Lists on ASX
|
|
snouty
|
149 |
62K |
1 |
10/07/19 |
10/07/19 |
ASX - By Stock
|
149
|
62K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Therapeutics Lists on ASX
|
|
snouty
|
149 |
62K |
1 |
09/07/19 |
09/07/19 |
ASX - By Stock
|
149
|
62K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Therapeutics Lists on ASX
|
|
snouty
|
149 |
62K |
2 |
08/07/19 |
08/07/19 |
ASX - By Stock
|
149
|
62K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: New HER-Vaxx Cancer Vaccine trial data presented at ESMO GI
|
|
snouty
|
77 |
36K |
4 |
08/07/19 |
08/07/19 |
ASX - By Stock
|
77
|
36K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Top 20 Holders
|
|
snouty
|
89 |
24K |
3 |
04/07/19 |
04/07/19 |
ASX - By Stock
|
89
|
24K
|
3
|
|
ASX - By Stock
|
IME |
Re:
News: IME ImExHS Ltd Announces Contract With Clínica Las Americas
|
|
snouty
|
159 |
40K |
2 |
24/06/19 |
24/06/19 |
ASX - By Stock
|
159
|
40K
|
2
|
|
ASX - By Stock
|
IME |
Re:
News: IME ImExHS Ltd Announces Contract With Clínica Las Americas
|
|
snouty
|
159 |
40K |
5 |
24/06/19 |
24/06/19 |
ASX - By Stock
|
159
|
40K
|
5
|
|
IPOs
|
IXC |
Re:
IXC - Invex Theraputics
|
|
snouty
|
113 |
71K |
2 |
19/06/19 |
19/06/19 |
IPOs
|
113
|
71K
|
2
|
|
IPOs
|
IXC |
Re:
IXC - Invex Theraputics
|
|
snouty
|
113 |
71K |
3 |
19/06/19 |
19/06/19 |
IPOs
|
113
|
71K
|
3
|
|
ASX - By Stock
|
HXG |
Re:
Ann: Trading Halt
|
|
snouty
|
76 |
24K |
1 |
06/06/19 |
06/06/19 |
ASX - By Stock
|
76
|
24K
|
1
|
|
ASX - By Stock
|
HXG |
Re:
Ann: Trading Halt
|
|
snouty
|
76 |
24K |
2 |
05/06/19 |
05/06/19 |
ASX - By Stock
|
76
|
24K
|
2
|
|
ASX - By Stock
|
HXG |
Re:
Ann: Trading Halt
|
|
snouty
|
76 |
24K |
4 |
04/06/19 |
04/06/19 |
ASX - By Stock
|
76
|
24K
|
4
|
|
ASX - By Stock
|
IME |
Re:
News: IME ImExHS Ltd Announces Contract With Clínica Las Americas
|
|
snouty
|
159 |
40K |
6 |
28/05/19 |
28/05/19 |
ASX - By Stock
|
159
|
40K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Appendix 4C - Quarterly and Business Update
|
|
snouty
|
37 |
15K |
5 |
16/04/19 |
16/04/19 |
ASX - By Stock
|
37
|
15K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Appendix 4C - Quarterly and Business Update
|
|
snouty
|
37 |
15K |
12 |
16/04/19 |
16/04/19 |
ASX - By Stock
|
37
|
15K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Appendix 4C - Quarterly and Business Update
|
|
snouty
|
37 |
15K |
14 |
16/04/19 |
16/04/19 |
ASX - By Stock
|
37
|
15K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Appendix 4C - Quarterly and Business Update
|
|
snouty
|
37 |
15K |
15 |
16/04/19 |
16/04/19 |
ASX - By Stock
|
37
|
15K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMU presents new mimotope PD-1 vaccine data at AACR
|
|
snouty
|
108 |
47K |
8 |
03/04/19 |
03/04/19 |
ASX - By Stock
|
108
|
47K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMU presents positive new HER-Vaxx data at AACR
|
|
snouty
|
39 |
12K |
19 |
02/04/19 |
02/04/19 |
ASX - By Stock
|
39
|
12K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMU presents positive new HER-Vaxx data at AACR
|
|
snouty
|
39 |
12K |
33 |
02/04/19 |
02/04/19 |
ASX - By Stock
|
39
|
12K
|
33
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene doses first patient in HER-Vaxx phase 2 trial
|
|
snouty
|
96 |
44K |
4 |
01/04/19 |
01/04/19 |
ASX - By Stock
|
96
|
44K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene doses first patient in HER-Vaxx phase 2 trial
|
|
snouty
|
96 |
44K |
9 |
31/03/19 |
31/03/19 |
ASX - By Stock
|
96
|
44K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene doses first patient in HER-Vaxx phase 2 trial
|
|
snouty
|
96 |
44K |
12 |
31/03/19 |
31/03/19 |
ASX - By Stock
|
96
|
44K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Company mis-guidance and funny buggers.
|
|
snouty
|
44 |
19K |
5 |
28/02/19 |
28/02/19 |
ASX - By Stock
|
44
|
19K
|
5
|
|
ASX - By Stock
|
IMU |
Key-vax
|
|
snouty
|
1 |
861 |
10 |
28/02/19 |
28/02/19 |
ASX - By Stock
|
1
|
861
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Hard to believe?
|
|
snouty
|
140 |
62K |
12 |
17/02/19 |
17/02/19 |
ASX - By Stock
|
140
|
62K
|
12
|
|
ASX - By Stock
|
IME |
Re:
Ann: ImExHS Announces an important new SaaS client in Ecuador
|
|
snouty
|
64 |
12K |
4 |
07/02/19 |
07/02/19 |
ASX - By Stock
|
64
|
12K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Leslie Chong Interview at Biotech Showcase
|
|
snouty
|
11 |
6.2K |
8 |
13/01/19 |
13/01/19 |
ASX - By Stock
|
11
|
6.2K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
New Paul Hopper Interview
|
|
snouty
|
26 |
9.4K |
1 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
26
|
9.4K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs PromarkerD agreement with US big pharma
|
|
snouty
|
63 |
28K |
11 |
26/11/18 |
26/11/18 |
ASX - By Stock
|
63
|
28K
|
11
|
|
ASX - By Stock
|
HXG |
Re:
Ann: Hexagon and Mineral Resources Sign McIntosh JV Agreement
|
|
snouty
|
25 |
11K |
0 |
22/11/18 |
22/11/18 |
ASX - By Stock
|
25
|
11K
|
0
|
|
ASX - By Stock
|
HXG |
Re:
Ann: Hexagon and Mineral Resources Sign McIntosh JV Agreement
|
|
snouty
|
25 |
11K |
1 |
22/11/18 |
22/11/18 |
ASX - By Stock
|
25
|
11K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD kit version complete- commercial release imminent
|
|
snouty
|
47 |
17K |
8 |
09/11/18 |
09/11/18 |
ASX - By Stock
|
47
|
17K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Appendix 4C - September 2018 Quarterly Report
|
|
snouty
|
15 |
4.4K |
3 |
08/11/18 |
08/11/18 |
ASX - By Stock
|
15
|
4.4K
|
3
|
|
ASX - By Stock
|
IME |
Re:
News: IME Imexhs Signs 5-Year Hirukotm Ris-Pacs Deal With Caja Colombiana De Subsidio Familiar
|
|
snouty
|
59 |
13K |
1 |
22/10/18 |
22/10/18 |
ASX - By Stock
|
59
|
13K
|
1
|
|
ASX - By Stock
|
IME |
Re:
News: IME Imexhs Signs 5-Year Hirukotm Ris-Pacs Deal With Caja Colombiana De Subsidio Familiar
|
|
snouty
|
59 |
13K |
0 |
22/10/18 |
22/10/18 |
ASX - By Stock
|
59
|
13K
|
0
|
|